These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 19481697)
61. The ester group: how hydrofluoroalkane-philic is it? Peguin RP; Wu L; da Rocha SR Langmuir; 2007 Jul; 23(16):8291-4. PubMed ID: 17602576 [TBL] [Abstract][Full Text] [Related]
62. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients. Dusser D; Vicaut E; Lefrançois G; Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009 [TBL] [Abstract][Full Text] [Related]
63. Understanding solvation in hydrofluoroalkanes: ab initio calculations and chemical force microscopy. Wu L; Peguin RP; da Rocha SR J Phys Chem B; 2007 Jul; 111(28):8096-104. PubMed ID: 17580855 [TBL] [Abstract][Full Text] [Related]
64. Particle synergy and aerosol performance in non-aqueous liquid of two combinations metered dose inhalation formulations: an AFM and Raman investigation. Rogueda PG; Price R; Smith T; Young PM; Traini D J Colloid Interface Sci; 2011 Sep; 361(2):649-55. PubMed ID: 21714970 [TBL] [Abstract][Full Text] [Related]
65. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations. Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971 [TBL] [Abstract][Full Text] [Related]
66. Evaluation of the Malvern Spraytec with inhalation cell for the measurement of particle size distribution from metered dose inhalers. Haynes A; Shaik MS; Krarup H; Singh M J Pharm Sci; 2004 Feb; 93(2):349-63. PubMed ID: 14705192 [TBL] [Abstract][Full Text] [Related]
67. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers. Smyth HD; Beck VP; Williams D; Hickey AJ AAPS PharmSciTech; 2004 Feb; 5(1):E7. PubMed ID: 15198528 [TBL] [Abstract][Full Text] [Related]
68. The formulation, chemical and physical characterisation of clarithromycin-based macrolide solution pressurised metered dose inhaler. Saadat A; Zhu B; Haghi M; King G; Colombo G; Young PM; Traini D J Pharm Pharmacol; 2014 May; 66(5):639-45. PubMed ID: 24329164 [TBL] [Abstract][Full Text] [Related]
69. Reverse aqueous emulsions and microemulsions in HFA227 propellant stabilized by non-ionic ethoxylated amphiphiles. Chokshi U; Selvam P; Porcar L; da Rocha SR Int J Pharm; 2009 Mar; 369(1-2):176-84. PubMed ID: 19028557 [TBL] [Abstract][Full Text] [Related]
70. Inhalation delivery of anticancer agents via HFA-based metered dose inhaler using methotrexate as a model drug. Shaik MS; Haynes A; McSween J; Ikediobi O; Kanikkannan N; Singh M J Aerosol Med; 2002; 15(3):261-70. PubMed ID: 12396414 [TBL] [Abstract][Full Text] [Related]
72. In vitro drug delivery performance of a new budesonide/formoterol pressurized metered-dose inhaler. Chambers F; Ludzik A J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):113-20. PubMed ID: 19422311 [TBL] [Abstract][Full Text] [Related]
73. In vitro characterization of the OptiChamber Diamond valved holding chamber. Hatley RH; von Hollen D; Sandell D; Slator L J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S24-36. PubMed ID: 25054480 [TBL] [Abstract][Full Text] [Related]
74. Influence of the valve lubricant on the aerodynamic particle size of a metered dose inhaler. Berry J; Kline L; Naini V; Chaudhry S; Hart J; Sequeira J Drug Dev Ind Pharm; 2004 Mar; 30(3):267-75. PubMed ID: 15109026 [TBL] [Abstract][Full Text] [Related]
75. The application of "in-flight" laser diffraction to the particle size characterization of a model suspension metered dose inhaler. Pu Y; Kline LC; Berry J Drug Dev Ind Pharm; 2011 May; 37(5):552-8. PubMed ID: 21126224 [TBL] [Abstract][Full Text] [Related]
76. [Progress of research on pressurized metered dose inhalers]. Zhou X Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):213-5. PubMed ID: 23856147 [No Abstract] [Full Text] [Related]
77. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. Laube BL Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400 [TBL] [Abstract][Full Text] [Related]
78. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study. Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114 [TBL] [Abstract][Full Text] [Related]
79. Fabrication of inhalable spore like pharmaceutical particles for deep lung deposition. Shen ZG; Chen WH; Jugade N; Gao LY; Glover W; Shen JY; Yun J; Chen JF Int J Pharm; 2012 Jul; 430(1-2):98-103. PubMed ID: 22486960 [TBL] [Abstract][Full Text] [Related]
80. Novel nanoparticles for pulmonary drug administration. Dickinson PA; Howells SW; Kellaway IW J Drug Target; 2001; 9(4):295-302. PubMed ID: 11697032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]